Total Payments
$44,121
2024 Payments
$137.35
Companies
48
Transactions
723
Medicare Patients
995
Medicare Billing
$121,174
Payment Breakdown by Category
Other$22,293 (50.5%)
Food & Beverage$10,296 (23.3%)
Travel$6,418 (14.5%)
Consulting$4,450 (10.1%)
Research$553.00 (1.3%)
Education$111.00 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21,393 | 10 | 48.5% |
| Food and Beverage | $10,296 | 680 | 23.3% |
| Travel and Lodging | $6,418 | 24 | 14.5% |
| Consulting Fee | $4,450 | 5 | 10.1% |
| Honoraria | $900.00 | 1 | 2.0% |
| Unspecified | $553.00 | 1 | 1.3% |
| Education | $111.00 | 2 | 0.3% |
Payments by Type
General
$43,568
722 transactions
Research
$553.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $16,972 | 65 | $0 (2022) |
| GENZYME CORPORATION | $10,922 | 33 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $6,541 | 250 | $0 (2020) |
| Genentech, Inc. | $1,404 | 5 | $0 (2019) |
| Biogen, Inc. | $915.75 | 38 | $0 (2023) |
| BANNER LIFE SCIENCES, LLC | $900.00 | 1 | $0 (2021) |
| ABBVIE INC. | $665.50 | 38 | $0 (2024) |
| Allergan, Inc. | $631.28 | 57 | $0 (2021) |
| Eli Lilly and Company | $553.00 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $481.72 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $137.35 | 7 | ABBVIE INC. ($61.62) |
| 2023 | $809.44 | 51 | AbbVie Inc. ($256.52) |
| 2022 | $271.55 | 13 | ABBVIE INC. ($217.18) |
| 2021 | $1,494 | 21 | BANNER LIFE SCIENCES, LLC ($900.00) |
| 2020 | $673.75 | 38 | Allergan, Inc. ($130.39) |
| 2019 | $4,668 | 199 | Genentech, Inc. ($1,404) |
| 2018 | $1,954 | 151 | Teva Pharmaceuticals USA, Inc. ($394.70) |
| 2017 | $34,113 | 243 | Sunovion Pharmaceuticals Inc. ($16,682) |
All Payment Transactions
723 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/16/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Neurology | ||||||
| 02/13/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $32.19 | General |
| Category: Musculoskeletal | ||||||
| 02/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: PAIN | ||||||
| 01/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: PAIN | ||||||
| 12/21/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/13/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: PAIN | ||||||
| 12/11/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Neurology | ||||||
| 12/07/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/17/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.73 | General |
| Category: PAIN | ||||||
| 11/17/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.15 | General |
| Category: PAIN | ||||||
| 11/16/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.11 | General |
| Category: PAIN | ||||||
| 11/13/2023 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Neuroscience | ||||||
| 11/10/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: PAIN | ||||||
| 11/03/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: PAIN | ||||||
| 10/31/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: PAIN | ||||||
| 09/22/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/24/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/24/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.14 | General |
| Category: PAIN | ||||||
| 08/09/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED AND DELAYED-START STUDY OF LY3314814 IN MILD ALZHEIMERS DISEASE DEMENTIA | Eli Lilly and Company | $553.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 182 | 260 | $76,180 | $25,460 |
| 2022 | 4 | 226 | 330 | $90,833 | $30,178 |
| 2021 | 5 | 273 | 368 | $102,334 | $34,805 |
| 2020 | 5 | 314 | 396 | $85,980 | $30,732 |
Total Patients
995
Total Services
1,354
Medicare Billing
$121,174
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 75 | 115 | $39,445 | $13,841 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 126 | $30,693 | $9,766 | 31.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $6,042 | $1,853 | 30.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 116 | 170 | $41,296 | $12,944 | 31.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 71 | 105 | $35,995 | $12,482 | 34.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $7,932 | $2,539 | 32.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 14 | 30 | $5,610 | $2,213 | 39.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 117 | 166 | $39,502 | $12,747 | 32.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 83 | 109 | $36,731 | $12,500 | 34.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 36 | 36 | $11,427 | $3,965 | 34.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 17 | 17 | $7,130 | $2,835 | 39.8% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 20 | 40 | $7,544 | $2,758 | 36.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 172 | 227 | $43,993 | $14,906 | 33.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 70 | 83 | $21,348 | $8,377 | 39.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 47 | 47 | $14,087 | $4,909 | 34.8% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 12 | 26 | $4,706 | $1,911 | 40.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 13 | 13 | $1,846 | $627.74 | 34.0% |
About Dr. Greg Anderson, MD
Dr. Greg Anderson, MD is a Clinical Neurophysiology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154368801.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Greg Anderson, MD has received a total of $44,121 in payments from pharmaceutical and medical device companies, with $137.35 received in 2024. These payments were reported across 723 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($21,393).
As a Medicare-enrolled provider, Anderson has provided services to 995 Medicare beneficiaries, totaling 1,354 services with total Medicare billing of $121,174. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Neurophysiology
- Location Lexington, KY
- Active Since 06/01/2006
- Last Updated 05/05/2019
- Taxonomy Code 2084N0600X
- Entity Type Individual
- NPI Number 1154368801
Products in Payments
- APTIOM (Drug) $16,972
- LEMTRADA (Drug) $10,526
- COPAXONE (Drug) $5,738
- BAFIERTAM (Drug) $900.00
- BOTOX (Biological) $751.45
- TYSABRI (Biological) $738.39
- AJOVY (Drug) $588.51
- ACTHAR (Biological) $329.79
- Aimovig (Biological) $323.87
- NURTEC ODT (Drug) $281.66
- UBRELVY (Drug) $231.40
- Rebif (Biological) $225.47
- MAYZENT (Drug) $212.49
- DISEASE STATE (Drug) $212.24
- Briviact (Drug) $185.42
- SAMURAI (Device) $169.38
- Vimpat (Drug) $151.91
- QULIPTA (Drug) $145.10
- NORTHERA (Drug) $138.63
- SOLIRIS (Drug) $135.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Neurophysiology Doctors in Lexington
Dr. Warren Chumley, Md, MD
Clinical Neurophysiology — Payments: $389,416
Clinical Neurophysiology $389,416
Dr. Ima Ebong, Md, MD
Clinical Neurophysiology — Payments: $14,651
Clinical Neurophysiology $14,651
Stephen Ryan, Md, MD
Clinical Neurophysiology — Payments: $213.92
Clinical Neurophysiology $213.92
Kevin Nelson, Md, MD
Clinical Neurophysiology — Payments: $95.04
Clinical Neurophysiology $95.04